Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Gynecology | Nursing | Pharmacy | Journal

Back to Journal Articles

Review Compares Effectiveness of Tocolytic Agents

Last Updated: October 10, 2012.

 

Prostaglandin inhibitors and calcium channel blockers most effective for delaying delivery

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The most effective tocolytic agents for delaying delivery and improving neonatal and maternal outcomes are prostaglandin inhibitors and calcium channel blockers, according to a meta-analysis published online Oct. 9 in BMJ.

WEDNESDAY, Oct. 10 (HealthDay News) -- The most effective tocolytic agents for delaying delivery and improving neonatal and maternal outcomes are prostaglandin inhibitors and calcium channel blockers, according to a meta-analysis published online Oct. 9 in BMJ.

David M. Haas, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a systematic review and network meta-analysis to assess the most effective tocolytic agent for delaying delivery.

Of 3,263 titles identified, 95 randomized controlled trials were reviewed. The researchers found that the probability of delivery being delayed by 48 hours was highest with prostaglandin inhibitors (odds ratio [OR], 5.39), followed by magnesium sulfate (OR, 2.76); calcium channel blockers (OR, 2.71); beta mimetics (OR, 2.41); and atosiban, the oxytocin receptor blocker (OR, 2.02), compared with placebo. Side effects necessitating a change of medication were significantly higher for beta mimetics (OR, 22.68), magnesium sulfate (OR, 8.15), and calcium channel blockers (OR, 3.80), compared with placebo. For the outcomes of 48-hour delay in delivery, respiratory distress syndrome, neonatal mortality, and maternal side effects, the tocolytics with the best probability of being ranked in the top three medication classes were prostaglandin inhibitors and calcium channel blockers.

"In this network meta-analysis, prostaglandin inhibitors and calcium channel blockers had the highest probability of delaying delivery and improving neonatal outcomes," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Full Text
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Hormone Replacement Therapy Initiated Early Deemed Safe Next: Portable Device Feasible for Donor Lung Preservation

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.